Ipilimumab Plus Nivolumab Effective for mRCC With Brain Metastases
Dual immunotherapy appears to have clinical efficacy beyond the first-line setting in patients with metastatic renal cell carcinoma with brain metastases.
Dual immunotherapy appears to have clinical efficacy beyond the first-line setting in patients with metastatic renal cell carcinoma with brain metastases.
In a small study, use of the potassium binder sodium zirconium cyclosilicate in transplant recipient did not appear to compromise immunosuppression with tacrolimus.
High CONUT scores were associated with adverse clinicopathological characteristics and worse survival in patients with localized upper tract urothelial carcinoma.
In a study of patients with upper tract urothelial carcinoma, variant vs conventional histology predicted worse survival.
Sterile pyuria may be a marker of inflammation, which is known to influence carcinogenesis.
Investigators found no meaningful survival difference between patients transitioning to home hemodialysis or peritoneal dialysis within 12 months of dialysis initiation.
Hemoglobin levels greater than the current recommendations of 10.0 to 11.5 g/dL are associated with improved health-related quality of life among anemic patients with chronic kidney disease not on dialysis, a study found.
The potential diagnostic harms of withholding group II gadolinium-based contrast agents may outweigh the risk of nephrogenic systemic fibrosis in advanced CKD patients, according to investigators.
Intravesical incision of the bladder cuff may be superior to other distal ureteral management techniques, according to investigators.
The incidence of distant metastatic prostate cancer increased gradually over 2010 to 2015, investigators reported.